Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis

Clin Infect Dis. 2013 Dec;57(12):1786-7. doi: 10.1093/cid/cit565. Epub 2013 Sep 17.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Hematopoietic Stem Cell Transplantation / mortality*
  • Humans
  • Invasive Pulmonary Aspergillosis / mortality*
  • Male
  • Mannans / blood*

Substances

  • Mannans